Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

House Speaker Paul RyanPaul Davis RyanUnscripted Trump keeps audience guessing in Rose Garden Coulter defends Paul Ryan: This is 100 percent Trump's fault The Hill's 12:30 Report — Presented by Kidney Care Partners — Trump escalates border fight with emergency declaration MORE (R-Wis.) on Wednesday said Rep. Chris CollinsChristopher (Chris) Carl CollinsFighting AIDS domestically and globally means pushing more evidence-based services House Dems unveil initial GOP targets in 2020 The Memo: Pelosi ups ante in Trump showdown MORE (R-N.Y.) has been removed from his post on the House Energy and Commerce Committee as a result of the lawmaker's indictment on insider trading charges.

Collins was arrested and charged with federal securities fraud related to an Australian pharmaceutical company of which he had been the largest shareholder.

ADVERTISEMENT

“While his guilt or innocence is a question for the courts to settle, the allegations against Rep. Collins demand a prompt and thorough investigation by the House Ethics Committee," Ryan said in a statement. "Insider trading is a clear violation of the public trust. Until this matter is settled, Rep. Collins will no longer be serving on the House Energy and Commerce Committee.”

House Majority Whip Steve ScaliseStephen (Steve) Joseph ScaliseOn unilateral executive action, Mitch McConnell was right — in 2014 Texas man with politician hit list, illegally 3D printed rifle sentenced to eight years The Hill's Morning Report - Presented by the American Academy of HIV Medicine - Will there be any last-minute shutdown drama? MORE (R-La.) backs the Speaker’s decision to remove Collins from the committee, a Scalise spokesman told The Hill.

According to the indictment, Collins's son, Cameron Collins, and Stephen Zarsky, the father of Cameron Collins's fiancée, are also being charged.

The Buffalo-area congressman turned himself in to the FBI and is slated to appear in court later in the day, NBC News reported.

An Office of Congressional Ethics report released in 2017 stated there is “substantial reason to believe” he shared nonpublic information about the Australian pharmaceutical company.